As of Feb 17
| +0.71 / +0.86%|
The 2 analysts offering 12-month price forecasts for Cantel Medical Corp have a median target of 91.50, with a high estimate of 100.00 and a low estimate of 83.00. The median estimate represents a +9.99% increase from the last price of 83.19.
The current consensus among 3 polled investment analysts is to Hold stock in Cantel Medical Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.